Literature DB >> 25796168

Serine/Threonine Protein Phosphatase-5 Accelerates Cell Growth and Migration in Human Glioma.

Xinglong Zhi1, Hongqi Zhang, Chuan He, Yukui Wei, Lisong Bian, Guilin Li.   

Abstract

Glioma is the most common type of primary central nervous system tumor. Ser/Thr protein phosphatase 5 (PP5) has been shown to regulate multiple signaling cascades that suppress growth and facilitate apoptosis in several human cancer cells. However, the role of PP5 in human gliomas remains unclear. Herein, the relationship between PP5 expression and glioma cell growth was investigated, and the therapeutic value of PP5 in glioma was further evaluated. We employed a short hairpin RNA targeting PPP5C gene to knock down PP5 expression in human glioma cell lines U251 and U373. Depletion of PPP5C via RNAi remarkably inhibited glioma cell proliferation and colony formation, and arrested cell cycle in the G0/G1 phase. Moreover, knockdown of PP5 markedly suppressed glioma cell migration, as determined by Transwell assay. Our findings suggest that PPP5C could be essential for glioma cell growth and serve as a promising therapeutic target in human gliomas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25796168     DOI: 10.1007/s10571-015-0162-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  34 in total

1.  The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant.

Authors:  M S Chen; A M Silverstein; W B Pratt; M Chinkers
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

2.  Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest.

Authors:  Z Zuo; N M Dean; R E Honkanen
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

3.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

4.  Proteomic analysis of mantle-cell lymphoma by protein microarray.

Authors:  Irene M Ghobrial; Daniel J McCormick; Scott H Kaufmann; Alexey A Leontovich; David A Loegering; Nga T Dai; Kelly L Krajnik; Mary J Stenson; Mona F Melhem; Anne J Novak; Stephen M Ansell; Thomas E Witzig
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

Review 5.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

Review 6.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

7.  Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade.

Authors:  Guofei Zhou; Teresa Golden; Ileana V Aragon; Richard E Honkanen
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

8.  Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression.

Authors:  Gudrun Urban; Teresa Golden; Ileana V Aragon; Lex Cowsert; Scott R Cooper; Nicholas M Dean; Richard E Honkanen
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

9.  Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1).

Authors:  Shile Huang; Lili Shu; Michael B Dilling; John Easton; Franklin C Harwood; Hidenori Ichijo; Peter J Houghton
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

10.  UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells: a model for cytochrome c resistance.

Authors:  Heather A Ferguson; Peter M Marietta; Carla L Van Den Berg
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

View more
  5 in total

1.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

2.  Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells in vitro.

Authors:  Jinhui Zhu; Yun Ji; Yuanquan Yu; Yun Jin; Xiaoxiao Zhang; Jiale Zhou; Yan Chen
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

Review 3.  Structure and function of the co-chaperone protein phosphatase 5 in cancer.

Authors:  Rebecca A Sager; Natela Dushukyan; Mark Woodford; Mehdi Mollapour
Journal:  Cell Stress Chaperones       Date:  2020-04-02       Impact factor: 3.667

4.  MiR-520a-5p/PPP5C regulation pattern is identified as the key to gemcitabine resistance in pancreatic cancer.

Authors:  Ruibiao Fu; Qian Shao; Bin Yang; Yan Chen; Qinghuang Ye; Xi Chen; Jinhui Zhu
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

5.  PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation.

Authors:  Jian-Min Lv; Lu Chen; Yi Gao; Hai Huang; Xiu-Wu Pan; Xi Liu; Ming Chen; Fa-Jun Qu; Lin Li; Jun-Kai Wang; Xin-Gang Cui; Dan-Feng Xu
Journal:  Onco Targets Ther       Date:  2018-09-12       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.